{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:38:19Z","timestamp":1794631099268,"version":"4.9.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Dengue virus (DENV) is a prevalent human pathogen, infecting approximately 400 million individuals per year and causing symptomatic disease in approximately 100 million. A distinct feature of dengue is the increased risk for severe disease in some individuals with preexisting DENV-specific immunity. One proposed mechanism for this phenomenon is antibody-dependent enhancement (ADE), in which poorly-neutralizing IgG antibodies from a prior infection opsonize DENV to increase infection of F\n                    <jats:sub>c<\/jats:sub>\n                    gamma receptor-bearing cells. While IgM and IgG are the most commonly studied DENV-reactive antibody isotypes, our group and others have described the induction of DENV-specific serum IgA responses during dengue. We hypothesized that monomeric IgA would be able to neutralize DENV without the possibility of ADE. To test this, we synthesized IgG and IgA versions of two different DENV-reactive monoclonal antibodies. We demonstrate that isotype-switching does not affect the antigen binding and neutralization properties of the two mAbs. We show that DENV-reactive IgG, but not IgA, mediates ADE in F\n                    <jats:sub>c<\/jats:sub>\n                    gamma receptor-positive K562 cells. Furthermore, we show that IgA potently antagonizes the ADE activity of IgG. These results suggest that levels of DENV-reactive IgA induced by DENV infection might regulate the overall IgG mediated ADE activity of DENV-immune plasma\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and may serve as a predictor of disease risk.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.777672","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:06:21Z","timestamp":1638295581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Adam D.","family":"Wegman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengsheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Endy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Gromowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1989.40.571","article-title":"Aedes Aegypti and Aedes Aegypti-Borne Disease Control in the 1990s: Top Down or Bottom Up. Charles Franklin Craig Lecture","volume":"40","author":"Gubler","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12060","article-title":"The Global Distribution and Burden of Dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0503","article-title":"Economic Impact of Dengue Illness in the Americas","volume":"84","author":"Shepard","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk Factors in Dengue Shock Syndrome: A Prospective Epidemiologic Study in Rayong, Thailand. I. The 1980 Outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.566","article-title":"Risk Factors in Dengue Shock Syndrome","volume":"56","author":"Thein","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0424","article-title":"Characteristics of Mild Dengue Virus Infection in Thai Children","volume":"89","author":"Yoon","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary Infection as a Risk Factor for Dengue Hemorrhagic Fever\/Dengue Shock Syndrome: An Historical Perspective and Role of Antibody-Dependent Enhancement of Infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue Antibody-Dependent Enhancement: Knowns and Unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol Spectr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.005","article-title":"Molecular Insight Into Dengue Virus Pathogenesis and Its Implications for Disease Control","volume":"162","author":"Diamond","year":"2015","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and Antibody-Dependent Enhancement of Dengue Viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence That Maternal Dengue Antibodies are Important in the Development of Dengue Hemorrhagic Fever in Infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1086\/648407","article-title":"Dengue Virus Infections and Maternal Antibody Decay in a Prospective Birth Cohort Study of Vietnamese Infants","volume":"200","author":"Chau","year":"2009","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3201\/eid0812.020170","article-title":"Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored","volume":"8","author":"Halstead","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal Antibody-Mediated Enhancement of Dengue Virus Infection In Vitro and In Vivo and Strategies for Prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/v2122649","article-title":"The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6836","article-title":"Antibody-Dependent Enhancement of Severe Dengue Disease in Humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41541-021-00339-y","article-title":"Enhanced Dengue Vaccine Virus Replication and Neutralizing Antibody Responses in Immune Primed Rhesus Macaques","volume":"6","author":"McCracken","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32834a1b0b","article-title":"Critical Issues in Dengue Vaccine Development","volume":"24","author":"Thomas","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and Risks of the Sanofi-Pasteur Dengue Vaccine: Modeling Optimal Deployment","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue Infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive Immune Responses to Primary and Secondary Dengue Virus Infections","volume":"19","author":"St John","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The Immune Geography of IgA Induction and Function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815001922","article-title":"A Meta-Analysis of the Diagnostic Accuracy of Dengue Virus-Specific IgA Antibody-Based Tests for Detection of Dengue Infection","volume":"144","author":"Alagarasu","year":"2016","journal-title":"Epidemiol Infect"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.12.4332-4338.2001","article-title":"Kinetics of Dengue Virus-Specific Serum Immunoglobulin Classes and Subclasses Correlate With Clinical Outcome of Infection","volume":"39","author":"Koraka","year":"2001","journal-title":"J Clin Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23833","article-title":"Dengue Specific Immunoglobulins M, A, and E in Primary and Secondary Dengue 4 Infected Salvadorian Children","volume":"86","author":"Vazquez","year":"2014","journal-title":"J Med Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-015-2519-7","article-title":"Higher Levels of Dengue-Virus-Specific IgG and IgA During Pre-Defervescence Associated With Primary Dengue Hemorrhagic Fever","volume":"160","author":"Bachal","year":"2015","journal-title":"Arch Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27298","DOI":"10.1038\/srep27298","article-title":"Dengue Specific Immunoglobulin A Antibody is Present in Urine and Associated With Disease Severity","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"102733","DOI":"10.1016\/j.ebiom.2020.102733","article-title":"Transcriptional and Clonal Characterization of B Cell Plasmablast Diversity Following Primary and Secondary Natural DENV Infection","volume":"54","author":"Waickman","year":"2020","journal-title":"EBioMedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"102482","DOI":"10.1016\/j.isci.2021.102482","article-title":"CD27(hi)CD38(hi) Plasmablasts are Activated B Cells of Mixed Origin With Distinct Function","volume":"24","author":"Rouers","year":"2021","journal-title":"iScience"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05237-11","article-title":"A Fusion-Loop Antibody Enhances the Infectious Properties of Immature Flavivirus Particles","volume":"85","author":"Rodenhuis-Zybert","year":"2011","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The Human Immune Response to Dengue Virus is Dominated by Highly Cross-Reactive Antibodies Endowed With Neutralizing and Enhancing Activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0008034","DOI":"10.1371\/journal.pntd.0008034","article-title":"Impact of Flavivirus Vaccine-Induced Immunity on Primary Zika Virus Antibody Response in Humans","volume":"14","author":"Malafa","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.67.102","article-title":"Susceptibility to Dengue Hemorrhagic Fever in Vietnam: Evidence of an Association With Variation in the Vitamin D Receptor and Fc Gamma Receptor IIa Genes","volume":"67","author":"Loke","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0199","article-title":"Association of FcgammaRIIa Polymorphism With Clinical Outcome of Dengue Infection: First Insight From Pakistan","volume":"93","author":"Mohsin","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0353","article-title":"Asymptomatic Dengue Infection in a Cuban Population Confirms the Protective Role of the RR Variant of the FcgammaRIIa Polymorphism","volume":"82","author":"Garc\u00eda","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.147.4.1338","article-title":"A Single Amino Acid in the Second Ig-Like Domain of the Human Fc Gamma Receptor II is Critical for Human IgG2 Binding","volume":"147","author":"Warmerdam","year":"1991","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00410-0","article-title":"The Role of IgG Fc Receptors in Antibody-Dependent Enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-1182","article-title":"Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared With Rituximab and Ofatumumab In Vitro and in Xenograft Models","volume":"12","author":"Herter","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc7303","article-title":"Antibody Fucosylation Predicts Disease Severity in Secondary Dengue Infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aai8128","article-title":"IgG Antibodies to Dengue Enhanced for FcgammaRIIIA Binding Determine Disease Severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"107642","DOI":"10.1016\/j.celrep.2020.107642","article-title":"Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants","volume":"31","author":"Thulin","year":"2020","journal-title":"Cell Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner","volume":"2","author":"Mehlhop","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00992-07","article-title":"Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies Against Dengue Type 2 and 4 Viruses are Controlled by Complement Levels","volume":"82","author":"Yamanaka","year":"2008","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.039","article-title":"Role of the Complement System in Antibody-Dependent Enhancement of Flavivirus Infections","volume":"103","author":"Byrne","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","article-title":"A Potent Neutralizing Antibody With Therapeutic Potential Against All Four Serotypes of Dengue Virus","volume":"2","author":"Xu","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal Antibody Enhancement of Dengue Disease in Mice is Prevented by Fc Modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization","volume":"45","author":"Kraus","year":"2007","journal-title":"J Clin Microbiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of Human Neutralizing Antibodies That Bind to Complex Epitopes on Dengue Virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1006487","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of Prior Flavivirus Immunity on Zika Virus Infection in Rhesus Macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.777672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T14:53:55Z","timestamp":1673880835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.777672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2021.777672"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.777672","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.14.460347","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2021.777672.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2021.777672.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"article-number":"777672"}}